To develop and validate a novel disease-specific questionnaire for measuring HRQoL in patients with Chronic Pulmonary Aspergillosis (CPA-HAQ) for use in clinical research, including clinical trials.
Study Type
OBSERVATIONAL
Enrollment
100
Ninewells Hospital & Medical School
Dundee, United Kingdom
RECRUITINGImperial College London
London, United Kingdom
RECRUITINGManchester NHS Foundation Trust
Manchester, United Kingdom
RECRUITINGImpact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being.
To develop and validate a novel disease-specific health-related quality of life (HRQoL) measure in chronic pulmonary aspergillosis (CPA): The Chronic Pulmonary Aspergillosis Health Assessment Questionnaire (CPA-HAQ)
Time frame: 30 months
Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being.
Testing the usability of a newly developed CPA-HAQ measure.
Time frame: 30 months
Impact of Chronic Pulmonary Aspergillosis (CPA) on health status and Well-being.
Correlating how HRQoL outcomes relate to existing disease prognostic markers.
Time frame: 30 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.